JP2014518267A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518267A5
JP2014518267A5 JP2014518932A JP2014518932A JP2014518267A5 JP 2014518267 A5 JP2014518267 A5 JP 2014518267A5 JP 2014518932 A JP2014518932 A JP 2014518932A JP 2014518932 A JP2014518932 A JP 2014518932A JP 2014518267 A5 JP2014518267 A5 JP 2014518267A5
Authority
JP
Japan
Prior art keywords
methyl
oxabicyclo
pyrido
ethyl
naphthyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014518932A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518267A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/044267 external-priority patent/WO2013003383A1/en
Publication of JP2014518267A publication Critical patent/JP2014518267A/ja
Publication of JP2014518267A5 publication Critical patent/JP2014518267A5/ja
Pending legal-status Critical Current

Links

JP2014518932A 2011-06-27 2012-06-26 細菌感染症の治療のための架橋二環式化合物 Pending JP2014518267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161501692P 2011-06-27 2011-06-27
US61/501,692 2011-06-27
PCT/US2012/044267 WO2013003383A1 (en) 2011-06-27 2012-06-26 Bridged bicyclic compounds for the treatment of bacterial infections

Publications (2)

Publication Number Publication Date
JP2014518267A JP2014518267A (ja) 2014-07-28
JP2014518267A5 true JP2014518267A5 (https=) 2015-08-06

Family

ID=46514782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014518932A Pending JP2014518267A (ja) 2011-06-27 2012-06-26 細菌感染症の治療のための架橋二環式化合物

Country Status (6)

Country Link
US (1) US20140243302A1 (https=)
EP (1) EP2723737A1 (https=)
JP (1) JP2014518267A (https=)
AU (1) AU2012275499A1 (https=)
CA (1) CA2840060A1 (https=)
WO (1) WO2013003383A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111705D0 (en) * 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
UA111861C2 (uk) 2011-11-15 2016-06-24 Такеда Фармасьютікал Компані Лімітед Ароматична гетероциклічна сполука дигідрокси
AR089929A1 (es) * 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
JP6112724B2 (ja) * 2013-10-31 2017-04-12 日本化薬株式会社 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤
WO2015103509A1 (en) 2014-01-06 2015-07-09 Bristol-Myers Squibb Company Pyrrolidinyl sulfone derivatives and their use as ror gamma modulators
EP3050888A1 (en) 2015-01-27 2016-08-03 Merck Sharp & Dohme Corp. Compounds for the treatment of bacterial infections
UY36851A (es) * 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2017153235A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-3-aryl-1-naphthamide und ihre verwendung
BR112018075297A2 (pt) * 2016-06-08 2019-03-19 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A composto, composição farmacêutica, e, método para tratar uma infecção bacteriana
HRP20220144T1 (hr) 2016-09-09 2022-04-15 Novartis Ag Spojevi i pripravci kao inhibitori endosomskih toll-u sličnih receptora
WO2019090074A1 (en) * 2017-11-02 2019-05-09 Calico Life Sciences Llc Modulators of the integrated stress pathway
JP7190513B2 (ja) 2018-06-15 2022-12-15 ブリストル-マイヤーズ スクイブ カンパニー ガレクチン-3抑制剤を模したテトラヒドロピラン系チオ二糖類
CN108947940A (zh) * 2018-06-20 2018-12-07 天津全和诚科技有限责任公司 一种2-氧杂环丁烷衍生物的合成方法
CA3125900A1 (en) 2019-01-08 2020-07-16 Kyorin Pharmaceutical Co., Ltd. 15-pgdh inhibitor
EP3911641A1 (en) 2019-01-14 2021-11-24 Innate Tumor Immunity, Inc. Nlrp3 modulators
US12304897B2 (en) 2019-01-31 2025-05-20 Kyorin Pharmaceutical Co., Ltd. 15-PGDH inhibitors
WO2021252775A1 (en) 2020-06-11 2021-12-16 Chdi Foundation, Inc. Heterocyclic compounds and imaging agents for imaging huntingtin protein
AU2021385752A1 (en) 2020-11-26 2023-06-29 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Fused tricyclic compound, preparation method therefor and application thereof in medicine
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR244550A1 (es) 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
CN100390178C (zh) 1999-11-12 2008-05-28 拜奥根Idec马萨诸塞公司 作为腺苷受体拮抗剂的多环烷基嘌呤
CA2580621A1 (en) * 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
ATE520687T1 (de) * 2007-06-15 2011-09-15 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyranderiva e
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
WO2010043714A1 (en) * 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
TW201022279A (en) * 2008-11-14 2010-06-16 Astrazeneca Ab Chemical compounds
CN102232078B (zh) * 2008-12-12 2014-07-16 埃科特莱茵药品有限公司 5-氨基-2-(1-羟基-乙基)-四氢吡喃衍生物
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen

Similar Documents

Publication Publication Date Title
JP2014518267A5 (https=)
JP2019536768A5 (https=)
JP2021534240A5 (https=)
JP2014513139A5 (https=)
RU2007147413A (ru) Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью
JP2015514808A5 (https=)
JP2013537210A5 (https=)
ME03754B (me) Derivaтi karbazola
JPWO2023018809A5 (https=)
JP2022500402A5 (https=)
TW200538128A (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
JPWO2023018810A5 (https=)
HRP20110457T1 (hr) Derivati piridina i njihova upotreba u liječenju psihotičnih poremećaja
JP2017535536A5 (https=)
SG172958A1 (en) Poly (adp-ribose) polymerase (parp) inhibitors
RU2014112931A (ru) Пиразолохинолиновое производное
JP2013500247A5 (https=)
JP2003528096A5 (https=)
RU2011117412A (ru) Трициклические оксазолидиноновые антибиотические соединения
JP2014521751A (ja) 腎髄質外層カリウムチャンネルの阻害薬
JP2014513140A5 (https=)
RU2010128543A (ru) Карбоксамидные соединения и их применение в качестве агонистов хемокиновых рецепторов
AR038366A1 (es) Compuestos de 1,2,4-triazolo [1,5-c] pirimidinas sustituidas, antagonistas del receptor de adenosina a2a, composiciones farmaceuticas, el uso de dichos compuestos para la manufactura de un medicamento para el tratamiento de enfermedades del sistema nervioso central y un kit que comprende combinacion
RU2010138648A (ru) Азатрициклические соединения антибиотиков